Axxcess Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.88M Buy
202,855
+9,902
+5% +$259K 0.08% 233
2026
Q1
$5.42M Sell
192,953
-17,222
-8% -$459K 0.17% 108
2025
Q4
$5.23M Buy
210,175
+6,661
+3% +$168K 0.09% 203
2025
Q3
$5.19M Buy
203,514
+43,296
+27% +$1.07M 0.11% 154
2025
Q2
$3.88M Sell
160,218
-2,808
-2% -$65.5K 0.09% 176
2025
Q1
$4.13M Sell
163,026
-31,881
-16% -$834K 0.11% 155
2024
Q4
$5.17M Buy
194,907
+1,696
+0.9% +$46K 0.12% 139
2024
Q3
$5.59M Sell
193,211
-26,738
-12% -$780K 0.14% 126
2024
Q2
$6.15M Sell
219,949
-8,171
-4% -$225K 0.16% 110
2024
Q1
$6.33M Buy
228,120
+10,384
+5% +$288K 0.17% 106
2023
Q4
$6.27M Buy
217,736
+36,311
+20% +$1.1M 0.18% 109
2023
Q3
$6.02M Buy
181,425
+116,243
+178% +$4.11M 0.21% 98
2023
Q2
$2.39M Sell
65,182
-54,100
-45% -$2.11M 0.17% 111
2023
Q1
$4.87M Sell
119,282
-537
-0.4% -$23.2K 0.37% 64
2022
Q4
$6.14M Buy
119,819
+51,734
+76% +$2.48M 0.51% 44
2022
Q3
$2.98M Buy
68,085
+528
+0.8% +$25.7K 0.28% 78
2022
Q2
$3.54M Buy
67,557
+9,854
+17% +$502K 0.33% 70
2022
Q1
$2.99M Sell
57,703
-5,725
-9% -$297K 0.23% 86
2021
Q4
$3.75M Buy
+63,428
New +$3.14M 0.27% 72

Other funds holding PFE

Axxcess Wealth Management's PFE Position: Q2 2026 in Review

Axxcess Wealth Management increased its Pfizer (PFE) stake by 5.1% in Q2 2026, buying an estimated $259K and bringing the position to 202,855 shares worth $4.88M. The position accounts for 0.08% of the portfolio, ranked #233.

Axxcess Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.33M in Q1 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Axxcess Wealth Management held 202,855 shares of Pfizer worth $4.88M as of Q2 2026.
  • Axxcess Wealth Management bought 9,902 Pfizer shares in Q2 2026, an estimated $259K.
  • Pfizer made up 0.08% of Axxcess Wealth Management's portfolio in Q2 2026, its #233 holding.
  • Axxcess Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Axxcess Wealth Management's Pfizer position peaked at $6.33M in Q1 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.